全球疫苗监管中的平台技术:开发,应用和监管策略与来自中国的见解
Xiaojing Li1, Su Jin1, Shuyang Guo1
1Center for Drug Evaluation, National Medical Products Administration, Zone 2, No. 22 Guangde Street, Beijing Economic and Technological Development Zone, Beijing 100076, China.
Vaccines
|January 8, 2025
概括
平台技术加速了疫苗开发和批准,简化了全球卫生监管流程. 协调国际法规对于应对"病原体X"等未来流行病的准备至关重要.
科学领域:
- 疫苗学和制药监管科学 疫苗学和制药监管科学
- 传染病的准备和应对情况.
背景情况:
- 平台技术已成为国际疫苗监管框架的重要组成部分,在埃博拉后和COVID-19大流行期间显著突出.
- 这项技术能够快速开发疫苗,优化监管途径,并增强全球公共卫生对传染病的反应.
- 在制定统一的全球定义和在监管提交中一致应用平台技术方面,仍然存在挑战.
研究的目的:
- 探索疫苗开发中与平台技术相关的演变,多样化的应用和监管策略.
- 分析中国在平台技术监管方面的具体经验和贡献,包括风险评估和加速批准.
- 突出平台技术在应对未来的流行病威胁方面的潜力,以及协调全球监管努力的必要性.
主要方法:
- 审查平台技术在疫苗开发和监管框架中的演变和应用.
- 分析中国对平台技术的监管方法,包括紧急疫苗批准和风险评估.
- 对国际监管实践和中国对全球协调贡献的比较研究.
主要成果:
- 平台技术显著简化了产品开发,可能减少或豁免某些临床试验,并促进监管提交.
- 中国的监管策略为风险评估和紧急疫苗的加速审批流程提供了宝贵的见解.
- 尽管取得了进展,但平台技术的统一全球定义和应用仍然是监管协调的挑战.
结论:
- 平台技术是提高疫苗开发和监管效率的变革性工具,对全球卫生安全至关重要.
- 中国的监管经验为基于风险的评估和加速途径提供了一个模型,有助于国际准备.
- 协调平台技术的全球监管工作对于有效打击未来的流行病至关重要,包括像"病原体X"这样的新兴威胁.
相关概念视频
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Drug Control Governance: Regulatory Bodies and Their Impact
139
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
139
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Vaccinations
44.0K
Overview
44.0K
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K


